Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.
Industry, Sector and Symbol
Stock Exchange OTCMKTS
Industry Pharmaceutical preparations
Sub-IndustryBiotechnology
SectorMedical
SymbolOTCMKTS:AFFY
CUSIP00826A10
Phone650-812-8700
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares37,490,000
Market Cap$880,000.00
Affymax (OTCMKTS:AFFY) Frequently Asked Questions
What is Affymax's stock symbol?
Affymax trades on the OTCMKTS under the ticker symbol "AFFY."
Who are some of Affymax's key competitors?
Some companies that are related to Affymax include Aoxing Pharmaceutical (AOXG), Integrated BioPharma (INBP), Capstone Therapeutics Corp Common Stock (CAPS), American Bio Medica (ABMC), Respirerx Pharmaceuticals (RSPI), Rosetta Genomics (ROSG), Generex Biotechnology (GNBT), GlobeImmune (GBIM), Argos Therapeutics (ARGS), Anthera Pharmaceuticals (ANTH), Global Future City (FTCY), Auris Medical (EARS), Aytu Bioscience (AYTU), Myrexis (MYRX) and Skinvisible (SKVI).
Who are Affymax's key executives?
Affymax's management team includes the folowing people:
- Mr. Mark G. Thompson, CFO & Sec. (Age 56)
- Mr. Jonathan M. Couchman, CEO, Pres & Director (Age 48)
- Dr. Tracy J. Dunn Ph.D., J.D., VP of Intellectual Property & Legal Affairs (Age 55)
Has Affymax been receiving favorable news coverage?
News articles about AFFY stock have trended somewhat positive on Sunday, Accern reports. The research firm identifies positive and negative media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Affymax earned a media and rumor sentiment score of 0.16 on Accern's scale. They also gave news headlines about the biopharmaceutical company an impact score of 46.12 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the next several days. View Recent Headlines for Affymax.
How do I buy shares of Affymax?
Shares of AFFY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Affymax's stock price today?
One share of AFFY stock can currently be purchased for approximately $0.0390.
How big of a company is Affymax?
Affymax has a market capitalization of $880,000.00.
How can I contact Affymax?
Affymax's mailing address is 19200 STEVENS CREEK BOULEVARD SUITE 240, CUPERTINO CA, 95014. The biopharmaceutical company can be reached via phone at 650-812-8700 or via email at [email protected]
MarketBeat Community Rating for Affymax (OTCMKTS AFFY)
MarketBeat's community ratings are surveys of what our community members think about Affymax and other stocks. Vote "Outperform" if you believe AFFY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AFFY will underperform the S&P 500 over the long term. You may vote once every thirty days.
